Global Wound Closure Products Market to Rise at 6.3% CAGR from 2014-2023 with North America Leading the Way

Transparency Market Research has published a new research report about the global wound closure products market. The research report, titled “Wound Closure Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” discusses the future of this market, keeping in mind the historical data and the various trends and dynamics governing it. Furthermore, this research report offers an in-depth explanation of new wound closure products and the growth of this market in the coming years. According to the research report, the global wound closure products market was valued at US$8.8 bn in 2014 and is expected to reach US$15.2 bn in 2023, surging at a CAGR of 6.3% from 2014 to 2023.

Wound closure is an exceptionally important part of surgeries and treating injuries to prevent the occurrence of dangerous infections. Surgical complications or any other complications can lead to serious complications, which could further result in amputations of limbs. Owing to these reasons, medical practitioners give special importance to wound closure in terms of materials used for treating wounds and the methods in which they treated.

The global wound closure products market is segmented on the basis of type and geography. On the basis of type, the global wound closure products market is segmented into sutures, surgical staples, wound closure strips, adhesives and tissue sealants, and hemostats. Geographically, this market is segmented into Europe, North America, Asia Pacific, Latin America, and Rest of the World.

Out of all the types of wound closure products, adhesives and tissue sealants are popularly used due to their advantage of faster wound closure. This not only saves the patient’s time, but also reduces the number of revisits to the hospital for the dressing of stitches or their removal. The adhesives and tissue sealants segment is further sub-segmented into fibrin sealants, cyanoacrylate sealants, collagen-based sealants, albumin and glutaraldehyde based sealants, and polymer based sealants. The research analysts predict that the demand for adhesives and tissue sealants will go up due to the aforementioned benefits. Tissue sealants are used with sutures and staples in specific surgical procedures such as heart valve replacement surgery and bariatric surgery.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5429

Geographically, North America held a dominant share in the global wound closure products market. This region represented a share of 39.5% in the overall market, with Europe following the market leader closely. The introduction of new medical devices is expected to drive the growth of the wound closure products market in these two regions in the coming years.

Some of the key players operating in the global wound closure products market are B. Braun Melsungen AG, C. R. Bard, Inc., Baxter International Inc., Covidien plc, Ethicon (Johnson & Johnson), and CryoLife amongst others. The research report profiles these players to explain the competitive landscape present in the overall market. Furthermore, the research report also provides a comprehensive outlook of the research and development strategies being carried out by these players to gain a competitive advantage. For a holistic point of view on the global wound closure products market, the research report has provided a detailed assessment of the financial overview, business and marketing ideas, and strategic mergers and acquisitions of these top players in the overall market.

Breast Pumps Market: Challenges and Opportunities

Breast pumps refer to the medical devices regulated by the U.S. Food and Drug Administration (FDA) used by the lactating mothers to ensure uninterrupted milk supply to their infants when away from home. Breast pumps based on the mode of operation are classified into four major types namely manual, single electric, double electric and hospital grade breast pumps. Based on the design, there are two main types of breast pumps available; closed and open systems. Open systems do not contain a barrier between the milk collection kit and the pump tubing due to which collected milk is susceptible to contamination, while closed pumps prevent contamination due to the presence of a barrier between the collection kit and pump tubing. Currently, majority of the breast pumps available represent closed systems. Changing lifestyles and increasing number of women prioritizing their career along with their child, have emerged as the major factors impacting the growth of this market. On the other hand, high cost of the devices followed by risk of contamination might limit the market growth. Increasing disposable incomes of respective nations will further propel the market growth.

Recommendation of breast pumps is majorly dependent on the frequency of breastfeeding; Double electric breast pumps are the most preferred pumps for frequent breastfeeding as it ensures efficient milk expression with less time consumption. While single electric breast pumps are the most preferred pumps over manual pumps owing to powerful motor capacity and variable suction pressures. Hospital grade breast pumps are usually recommended in the initial phase of breastfeeding mainly to establish milk supply and get acquainted with the use of pumps. These pumps are by far the most superior types of breast pumps due to powerful motor, effective pumping capacity and can support multiple users. Distribution channel of personal grade breast pumps varies from hospital grade breast pumps; durable medical equipment (DME) supplier or retailer or online sales channel forms the base of personal grade breast pumps, while hospital grade pumps reaches to the end users via hospitals. Electric breast pumps are preferred over manual breast pumps due to several beneficial features such as electric motor support, effective milk expression and less time consumption.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=687

The global market for breast pumps is analyzed from two perspectives; product type and geography. Manual, single electric, double electric and hospital grade breast pumps are the four major product types. Single electric breast pumps market is the largest market in 2013 owing to the reasonable price and several benefits over the manual pumps. In terms of volume, manual breast pumps constitute the leading market segment owing to its low cost and easy availability. Double electric breast pumps market segment is anticipated to be the fastest growing segment owing to best option available after hospital grade breast pumps. This is attributed to certain features such as easy and efficient milk expression solution for mothers who have to express milk several times a day and on a daily basis. In addition, these pumps are available with adjustable suction cycles; they start with shorter but quicker sucks in order to accelerate the letdown response, followed by longer, deeper and slower sucks.

Geographically, breast pumps market is studied for four regions: North America, Europe, Asia Pacific and Rest of the World. These regions are further analyzed by country. In terms of Revenue, North America accounted for the largest market share in 2013, owing to increasing breastfeeding rates and increasing awareness about breastfeeding. In terms of volume, North America leads the breast pumps market. Key players operating in the global breast pumps market include Medela AG, Ameda AG, Pigeon Corporation, Royal Philips Electronics NV, NUK USA LLC and Lansinoh Laboratories, Inc.

Electric Handheld BP Devices Market Trends & Forecast up to 2019

Transparency Market Research, a leading provider of the latest market intelligence, has compiled a vast array of data on the medical devices industry over the years. The most recent research effort has been conducted under the title “Electric Handheld BP Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” All factors that are influencing the global electrical handheld BP devices market have been incorporated in this study.

According to the World Health Organization, in 2008, almost a billion people around the world were suffering from uncontrolled blood pressure issues. This had emerged as a major growth force for the global electrical handheld BP devices market, especially in the technological developments department. As it stands, there is a major need across the world for medical devices that are portable, easy to use, and minimally invasive.

One of the greatest drivers of the global electrical handheld BP devices market currently is the high prevalence of chronic diseases across the world. Blood pressure is one of the most common vitals that need to be regularly checked for patients of chronic diseases and therefore, the global electrical handheld BP devices market is expected to exhibit a high growth rate. Its growth rate will be directly proportional to the number of diagnoses of chronic diseases.

Other drivers of the global electrical handheld BP devices market include the increasing rate of awareness among patients regarding the modern devices available in this market and the various technological developments and innovations. One of the greater innovations is a reduction in the size of several electronic devices, which is making it possible for patients to easily carry the devices around.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1606

The leading region in terms of consumption as well as research and development efforts in the global electrical handheld BP devices market has been North America. This region is followed by Europe and then Asia Pacific, which is presenting rapid growth. The growth of Asia Pacific can be attributed to the high population density and the growing diagnosis rates of chronic disorders. One of the greatest market opportunities is being presented by the Latin America electrical handheld BP devices market owing to major steps taken by Brazil and Mexico in the healthcare industry.

The list of key players in the global electrical handheld BP devices market includes A & D Medical, Microlife, Mabis Healthcare, Inc., Medisana AG, Braun GmbH, American Diagnostic Corp, Welch Allyn, Omron Healthcare Co., Ltd., and Philips Healthcare.

Global Demand for Body Contouring Devices Market

A new study on the global body contouring devices market by Transparency Market Research (TMR) states that the increasing consciousness pertaining to one’s physical appearance has been fueling the demand for body contouring devices across the world over the last few years. The report is titled “Body Contouring Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

As per the study, the increasing prevalence of obesity among young individuals is anticipated to boost the worldwide body contouring devices market during the forecast period. However, the high cost associated with aesthetic procedures is likely to limit the growth of this market to some extent in the coming years.

The type of body contouring device and the regional distribution of the worldwide body contouring devices market have been taken as the main considerations for the analysis in this report. Based on the type of device, the study broadly classifies the market into the invasive devices segment, the minimally invasive devices segment, and the non-invasive devices segment.

The invasive devices segment includes ultrasound-assisted liposuction devices, the minimally invasive devices segment comprises radiofrequency assisted liposuction devices and laser assisted lipolysis devices, and the non-invasive devices segment consists of radiofrequency lipoplasty devices.

Geographically, the report has segmented the global body contouring devices market into Asia Pacific, Europe, North America, and the Rest of the World. North America holds the largest share in the overall market.

The increasing number of individuals concerned about their physical appearances is the key factor propelling this market in North America. A rise in the obese population is another significant driving force behind the growth of the North America body contouring devices market. Mexico has emerged as the leading domestic market for body contouring devices in this region, notes the research study.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1511

Analysts also project the body contouring devices markets in Europe and Asia Pacific to witness remarkable growth in their global share. While the increasing disposable income of people in developing economies such as China and India is likely to fuel the demand for these devices in Asia Pacific, the Europe body contouring devices market is expected to be driven by the easy availability of technically advanced devices.

An analysis of the competitive landscape prevalent in the global body contouring devices market has also been presented in this report. According to it, Syneron Medical Ltd., Palomar Medical Technologies, Valeant, Lumenis, Meridian Co. Ltd., Alma Lasers Ltd., and Cynosure are the leading producers of body contouring devices across the world.

Other significant companies operational in the worldwide market for body contouring devices are Andrew Technologies, BTL Industries, Cutera, GlobalMed Technologies, Human Med, Invasix Aesthetic Solutions, Misonix, VLCC Health Care Ltd., and YOLO Medicals, reports the research study.

Radiopharmaceuticals Market Witnesses Rising Demand and Investment from R&D Activities

Transparency Market Research has announced the release of a new market research report examining the global radiopharmaceuticals market. The report analyzes historical statistics concerning the market and dominant market trends affecting the dynamics and future alteration of the market. It breaks down the market by various criteria for a comprehensive understanding of the market and profiles major companies operating in the global radiopharmaceuticals market to provide an understanding of the competitive landscape of the market.The report, titled “Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”, puts the market statistics regarding radiopharmaceuticals under the microscope in a variety of ways. It analyzes the supply chain analysis of the global radiopharmaceuticals market to understand the dynamics of the market and examines the impact analysis of the various major factors that govern the market’s development both positively and negatively.

Thus, the report will help clients identify potential barriers and formulate market strategies keeping those in mind, indicate emerging and monopoly markets to invest in, and help conceptualize the development of total solutions.The report identifies the growing incidence of cancer and increasing preference for extremely specific remedies targeted at particular conditions as the major growth drivers for the global radiopharmaceuticals market. Cancer therapeutics involving radiopharmaceuticals are a major trend expected to propel the growth of the market thanks to the increased ease it offers to the patient, particularly in contrast with the conventional chemotherapy. In addition, increasing use of radiopharmaceuticals in molecular imaging is also helping the global radiopharmaceuticals market grow at a healthy rate.

The global radiopharmaceuticals market was worth US$3.8 billion in 2011 and is expected to be growing at a stupendous CAGR of 18.3% to reach a value of US$12.2 billion by 2018.This high growth rate is calculated taking into account various market restraints such as the stringent regulatory frameworks that regulate the storage and usage of radiopharmaceuticals all over the world, a global shortage of supply, and the strengthening threat from substitute treatments.The report categorizes the global radiopharmaceuticals market on the basis of the end user applying the radiopharmaceuticals, the application of the radiopharmaceuticals, and the geographical distribution of the global market. It also categorizes the radiopharmaceutical generator market on the basis of the radioactive isotope used in it.Mo-99/Tc-99m generators took up an overwhelmingly dominant share of the global radiopharmaceuticals market, leading other segments such as Sr-82/Rb-82 generators, Ge-68/Ga-67, 68 generators, Sr-90/Y-90 generators, and W-188/Re-188 generators.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213

“The technetium isotope Tc-99m has established marketing channels in the global market but the other segments are expected to make heavy inroads into the dominance of Tc-99m generators in the forecast period. In fact, all other segments of generators are expected to grow at double-digit CAGRs during the forecast period,” a TMR analyst said.

According to application, the global radiopharmaceuticals market is divided into the use of radiopharmaceuticals for diagnosis, which includes the techniques of SPECT and PET and has applications in oncology, cardiovascular disorders, and others such as neurology and gastrointestinal disorders; and the use of radiopharmaceuticals for therapy, inclusive of the various isotopes used in cancer treatment and the treatments used in other types of disorders such as cardiovascular and neurological. Oncology dominates the global market for radiopharmaceuticals comprehensively.

Epidermal Growth Factor Receptor Antibodies Market Outlook and Forecast up to 2023

The epidermal growth factor receptor (EGFR) is defined as a transmembrane tyrosine kinase receptor involved in the survival and proliferation of the cancerous cells. Any kind of mutations affecting these EFGR receptors or activity could results in cancer. Mutations lead to over-expresion resulting in large number of cancer, including lung cancer, anal cancer and glioblastoma multiforme. EGFR receptors are the first molecule target against which monoclonal antibodies (mAb) have been designed for cancer treatment. These monoclonal antibodies are sometimes also referred as EGFR antibodies. EGFR antibodies market can be segmented on the basis of the major antibodies which are used against EGFR receptors which include:

• Cetuximab
• Panitumumab
• Nimotuzumab

Cetuximab (erbitux) and panitumumab (vecitibix) are the most preferred biosimilar EGFR antibodies which are used for treatment of cancer. These antibodies have demonstrated efficacy in the treatment of colorectal cancer as single agents and in combination with conventional chemotherapy. Since the US Food and Drug Administration (FDA) had approved cetuximab in 2003 and panitumumab in 2006, EGFR antibodies have become primary step of treatment algorithms for colorectal cancer. However, nimotuzumab is a humanized monoclonal antibody that as of 2014 is recognized under orphan drugs status in the U.S. and the European Union for the treatment of glioma. This drug has also achieved marketing approval in India and China for squamaus cell carcinoma of the neck and head, and is currently undergoing numerous clinical trials.

Additionally, many market players and research institutions are performing research activities on development of the biosuperior EGFR antibodies against cancerous cells. The most common biosuperior EGFR antibodies include engineered EGFR antibodies, Bi- and Multi-specific EGFR antibodies and EGFR antibody drug conjugates. As for instance, Hoffmann-La Roche is performing a phase 1b study of MPDL3280A (and engineered antibody) in combination with Tarceva in patients suffering from non-small cell lung cancer. Such extensive research and development activities associated with the development of EGFR antibodies biosuperiors is the major factor which is driving this market. However, the high cost associated with research activities and sunk cost involved in R&D activities restrains the EGFR antibodies market.

Download Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7325

Moreover, the increasing incidence of cancer worldwide is also demanding for the more effective treatment methods, which is encouraging the researchers to develop EGFR antibodies. According to World Health Organization (WHO), cancer was the leading cause of death in 2012, accounting for 8.2 million deaths worldwide. Lung, liver, colorectal, stomach and breast cancers were responsible for most of the deaths every year. Statistics also revealed that breast cancer incidence had risen by more than 20% in 2012 from 2009, while breast cancer mortality rate has increased by 14%. Due to harsh lifestyle, excessive intake of alcohol and smoking habits, the incidence of cancer is increasing rapidly worldwide, especially in developed economies of North America and Europe. Increasing morbidity and mortality rate among the cancer patients is fuelling the demand for EGFR antibodies, hence driving the market.

Some of the market players which are actively contributing towards EGFR antibodies market include Amgen, Inc., Eisai, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Biocon Ltd., Takeda Pharmaceutical Company, Ltd. and Immunogen, Inc.

Increasing Popularity of Anti-Wrinkle Products to Fuel Asia, Europe, and South America Anti-Aging Market

According to a new market study published by Transparency Market Research, the Asia, Europe, and South America anti-aging market will log a CAGR of 9.3% from 2014 to 2020. As a result, the market’s valuation of US$15.28 bn in 2012 will increase to US$30.92 bn by 2020. The report, titled “Asia, Europe, and South America Anti-aging Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” is available for sale on the company’s website.

Aging is a natural phenomenon that occurs as a living being becomes older. Aging can refer to either a single cell in organisms or can refer to the population of a species. As more consumers lay increased emphasis on maintaining a youthful appearance, cosmetologists and healthcare experts are striving to find solutions to restore younger looks and defy the signs of aging.

Read Full Asia, Europe, and South America Anti-aging Market Report

Presently, the rising awareness among individuals to look healthy and beautiful is primarily driving the anti-aging market globally. Moreover, an increasing geriatric pool in Europe that gives high importance to younger looks and aesthetics is driving this regional market for anti-aging products and services. In addition, the increasing awareness about the signs of aging in generation X and generation Y is supporting growth of the anti-aging market.

The easy availability of a large number of products for varying anti-aging needs, which are also affordable, is also propelling the growth of the anti-aging market in Europe, South America, and Asia. On the other hand, the presence of a large number of players is preventing the emergence of a clear leader in the market and causing fragmentation in revenues.

On the basis of product, anti-wrinkle products represented the largest segment in Asia in 2013. The availability of a large range of anti-wrinkle products and rising awareness resulting from promotional campaigns are the primary factors fueling the demand for these products in Asia. Grey hair and wrinkles are among the most common signs of aging and start appearing around 30 years of age. As 40% of the Asian population falls within the 25 to 50 years bracket, the demand for anti-wrinkle products is steep in this region. Likewise, the anti-wrinkle product segment led the Europe anti-aging products market in 2013. This is mainly due to the high awareness among individuals about the availability of anti-wrinkle products marketed under various brand names.

Request For Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5021

In 2013, in Europe, laser aesthetic devices stood as the largest device segment due to their efficacy. Moreover, the permanent nature of laser procedures combined with an extensive demand for cost-effective portable devices augurs well for laser aesthetic devices. In 2013, laser aesthetic devices led the Asia ant-aging devices market as well. In the 2014-2020 period, the increasing obese population, higher demand for anti-cellulite devices due to their non-invasive nature, and preference for portable devices will fuel the growth of the laser aesthetic devices market.

Some of the top companies operating in the Asia, Europe, and South America market for anti-aging are Allergan Inc., Beiersdorf AG, Cynosure Inc., Lumenis Ltd., Personal Microderm, Alma Lasers Ltd., Coty Inc., L'Oreal SA, PhotoMedex Inc., and Solta Medical Inc.

Surgical Stapling Devices Market Trends and Forecast 2016 – 2024

Global Surgical Stapling Devices Market: Overview

Surgical stapling devices were developed in response to rising concerns regarding the healing of traditional sutures. Compared to modern surgical staplers, sutures are more prone to separation and leaks. Additionally, surgical stapling devices offer a number of advantages over sutures such as accuracy, speed, and evenness of wound closure.

According to the US Food and Drug Administration (FDA), surgical staplers have been on the market for years now and these complex mechanical medical devices have been maturing in their technology. Employed in gynecologic, gastrointestinal, thoracic, and several other surgeries, surgical stapling devices are used to cut through tissues and organs, to remove part of an organ, and to develop connections between structures.

Two major types of surgical stapling devices are available in the market: manual and powered. These devices can be either reusable or disposable. Either way, both types are loaded with disposable cartridges. Geographically, the global surgical stapling devices market covers four main segments: Asia Pacific, North America, Europe, and Rest of the World.

This report offers readers a comprehensive and objective assessment of the global surgical stapling devices market and serves as an ideal blueprint for those looking to expand or enter into a business in this avenue. Supported with accurate facts and figures pertaining to the historical, current, and future performance of the surgical stapling devices market, the report offers actionable insights into where the market is headed and the key factors driving and hampering its growth. The most prominent players competing in the space are also highlighted and reviewed based on recent developments, product portfolio, business strategies, and financial standing.

Global Surgical Stapling Devices Market: Key Trends and Opportunities

The global surgical stapling devices market is single-handedly propelled by the rise in the number of surgeries performed around the world. The demographic trend of increasing geriatric population, growing prevalence of chronic diseases, presence of favorable reimbursement scenarios in developed and developing countries, and advancing medical tourism industry have contributed toward the increase in cardiovascular, neurological, and orthopedic surgeries, among others. This growth in surgical procedures has boosted the demand for surgical stapling devices significantly. Advent of new technologies, highly developed health care infrastructure in developed countries, rising demand for powered surgical instruments and accessories in emerging economies, and growing accessibility to health care facilities in developing countries are the other factors contributing to the expansion of this market.

Global Surgical Stapling Devices Market: Region-wise Outlook

Europe and North America are the dominant regional markets for surgical stapling devices and are likely to retain their lead during the forecast period. These regions are primarily driven by the early acceptance of advanced product innovations and technically advanced equipment. Asia Pacific is a much smaller market compared to the aforementioned developed markets; however, the potential for growth in the region is exceptional.

The RoW segment of the global market also holds immense scope for growth. The patient pool in Asia Pacific and RoW is high, thus translating into an increased number of surgical procedures and soaring demand for surgical stapling devices. Rising awareness about the availability and use of advanced surgical equipment and increasing health care expenditure in several developing countries are also likely to boost the surgical stapling devices market in Asia Pacific and RoW.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11384

Conmed Corporation, Alcon Laboratories Inc., KLS Martin Group, Zimmer Holdings Inc., Stryker Corporation, Ethicon Inc., Smith & Nephew PLC, Medtronic Inc., and CareFusion Corporation are some of the leading players operating in the global surgical stapling devices market.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Global Intrathecal Pumps Market Anticipated to Reach US$0.26 bn by 2020, Driven by High Incidence of Chronic Illnesses

Intrathecal pump is a surgically implanted system used to infuse potent medication directly into or around the spinal cord. These pumps are typically intended for use in chronic pain and spasticity management for delivering potent medicines in the intrathecal space which allows administration of drugs in very low doses. This significantly reduces the side effects associated with the drugs. The global intrathecal pumps market was valued at USD 199.8 million in 2013, and is expected to grow at a CAGR of 4.1% to reach an estimated value of 264.8 million by 2020.

The global intrathecal pumps market is witnessing healthy growth amidst the frequent product recalls. Driving factor for the market growth is the device’s ability to reduce debilitating pain and drug administration in low doses. This benefits patients with lesser side effects and more rapid therapeutic effects compared to other forms of medication. Chronic pain affecting approximately 20% to 30% of the U.S. population is the largest driver for intrathecal pumps. The prevalence of chronic pain is also severe in other parts of the world. In 2013, the market for these pumps was largely driven by demand for treating chronic pain and this application alone contributed to more than two-third of the total market revenue. The pain management application is expected to maintain its top position during the forecast period from 2014 to 2020 due to large untapped patient base and wider side effects of existing opioid analgesics administered via routes other than intrathecal.

Geographically, the global intrathecal pumps market is segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World. In 2013, North America was the largest market for intrathecal pumps followed by Europe and accounted for more than half of the revenue share in the market. This geography is expected to register a growth at a CAGR close to 4% during the forecast period. The improving healthcare infrastructure in Asia-Pacific region, particularly in China and India, large patient base with chronic pain and improving economies are propelling the growth of intrathecal pumps market in this region.

The global intrathecal pumps market is governed by very few players such as Medtronic, Inc., Flowonix Medical, Codman & Shurtleff, Inc. (a Johnson & Johnson company), and Tricumed Medizintechnik GmbH. Though several product recalls by leading companies in the market have hampered the market growth to some extent, many new companies are trying to enter the market to explore the untapped opportunities in the future.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1599

Cancer Treatment to Account for High Usage of Infusion Pumps

As per the data from the International Agency for Research on Cancer (IARC), the number of new cancer cases rose to 14.1 million in 2012 and the number of cancer deaths was recorded to be approximately 8.2 million. With prevalence of the disease in such a large magnitude, there is substantial demand for infusion pumps for cancer treatment. Hence, with higher safety and efficacy of drugs delivered through infusion pumps, the market for intrathecal pumps will expand rapidly in the coming years.

With technological developments, researchers have developed and manufactured infusion pumps that have the capability to deliver multiple medications using the same infusion pump. However, the use of a single drug reservoir for multiple medications can cause drug stability issues and a complex dosing challenge for concentration and administration rate for each drug. Hence, product modification and development is still needed for precise and accurate drug administration with low error rates.

Video Telemedicine Market Offering High-growth Opportunities for Market Players

Video communication has been the topic of fascination since the era of the cold war between the United States and the Soviet Russia. Earlier even a small glimpse of human form was considered an achievement. Today, modern technology has advanced to such an extent that even HD video is considered as primitive. This has been possible with the implementation of broadband networks all across the United States and other western countries that have enabled the west to rely on an infrastructure as a fundamental layer for the advancement of video conferencing solutions. The progress in video conferencing technology can be attributed to the three facets that support the industry, namely: device manufacturers, network solution providers and system integrators. The cumulative progress of these industry segments have lead to the overall growth of the video conferencing market, and thereby the video telemedicine applications. Telemedicine during the 1980’s relied heavily on the audio conferencing technology; video conferencing was implemented but with little success as the quality of the video transferred was not great on a dial up connection network. With the integration of fiber optic broadband system and high quality video sensors and webcams, video telemedicine has been touted by many as a revolution in modern medicine enabling face to face visit. Video telemedicine is therefore expected to replace traditional medicine in most aspects, in the near future. With technology advancing at a high pace, this possibility shall soon be a reality.

The video telemedicine market is primarily categorized into communication technology and applications. The application segment includes cardiology, neurology, dermatology, orthopedics, oncology, radiology, gynecology, pathology, and dentistry. Gynecology is the segment leader in terms of market revenue among the application areas of video telemedicine. Increasing awareness among women regarding female health risks and rising favor of privacy enabled doctor consultations have lead to the growth of video consultations in gynecology segment. However, neurology segment is witnessing the fastest growth owing to rising number of psychiatric consultation cases. Besides, a range of neurological disorders and conditions such as stroke, Alzheimer’s and Parkinson’s have ensured long term chronic care patient returns that result in increased video consultations. Dentistry, dermatology, oncology and radiology segments however will undergo reserved growth during the forecast period. The application areas such as pathology and cardiology are expected to demonstrate growth potential in the future beyond the forecast period although their present growth rate is not significant. This may be attributed to the increasing prevalence of cardiology diseases and rising concerns regarding contagious infections.

Among the various communication technologies used in video telemedicine, ADSL (Asymmetric Digital Subscriber Line) leads the present video telemedicine market in 2013. On the other hand, 4G (LTE, Wimax, Others) is expected to exhibit the highest growth rate for the forecast period. This can be attributed to the widely present fixed line communication networks such as ADSL and ISDN that are available globally. 4G technologies on the other hand are presently restricted to the western countries where it observes great support and growth and is yet to gain interest in the emerging markets of the Asia Pacific region. 3G technologies come close to being the second most growing technology in video telemedicine. Satellite communication and broadband ISDN (Integrated Services Digital Network) are communication technologies that have an attractive growth potential; however they consist of a smaller fraction of the overall global video telemedicine market.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=536

Geographically, North America was the largest video telemedicine market in terms of revenue for the year 2013 followed by the Europe. The fastest growth is also attributed to North America due to the highly developed and penetrated video telemedicine market in the U.S. Telemedicine itself has roots within the United States and shall continue to directly encourage growth within the video telemedicine solution with the advancement of technology and the rising cost of healthcare in the country. The Asia Pacific region exhibits second fastest growth rate during the forecast period. Rapidly growing population and increasing government initiatives in emerging countries such as China and India are some of the primary reasons why this region boasts of a high growth rate. In addition, the existence of a large number of device manufacturing companies making cheaper equipment and increasing penetration of network providers will ensure steady market penetration and growth for the future.

The video telemedicine market is observed to comprise mainly of device manufacturers, system integrators and network solution providers. Few players present themselves as the largest players in the global video telemedicine market. Among device manufacturers, the largest players are: Logitech International S.A and AMD global Telemedicine. Among network service providers Cisco Sytems Inc. was the largest player and among system integrators Polycom Inc. was the largest player. Overall, in the global video telemedicine market, Cisco Systems, Inc. have the largest global presence, offering a wide range of video telemedicine solutions and services worldwide. Their market presence in emerging markets and expertise in providing software solutions paved the way to their stronghold in the industry. Other companies include Siemens Healthcare, Sony Corporation, GlobalMed Inc., VSee lab Inc., Vidyo Inc., Vermont Tel, LifeSize Communication Inc., Permier Global Services Inc., Huawei Technologies Co Ltd and ZTE Corporation.

Global Hemostasis Market set for a Rapid Growth by 2013 – 2019

Hemostasis is the procedure of interaction between blood vessels, platelets and coagulation protein to stop bleeding. Sometimes, bleeding disorder occurs due to vascular and coagulation abnormalities. These abnormalities could be inherited or acquired. Acquired disorders are the most common by far, majorly thrombocytopenia and other abnormalities include trauma, anticoagulant rodenticide, vitamin K deficiency, disseminated intravascular coagulation (DIC), Von Willebrand disease (vWD), deficiency of intrinsic and extrinsic factors, dysfibrinogenemia, Monoclonal Gammopathy and congenital platelet function defect. The hemostasis market is segmented into three major categories based on the types of products, as topical hemostats, infusible hemostats and advanced hemostats and sealants. Topical hemostats are further fragmented into three main segments which include:

• Collagen
• Oxidized regenerated cellulose (ORC)
• Gelatin

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2401

Topical hemostats are mostly used in surgery settings for hemostatis. Collagen among these is majorly used as it acts immediately and starts blood clotting by natural pathway. Topical agents are preferred over other agents due to their ease of use, efficiency, biodegradable nature and cost effectiveness. The other major method to treat hemostasis disorder is by using infusible hemostats. The major products which consist of infusible hemostats include:

• Platelet concentrates from donor blood
• FVIII derived from blood
• Fresh frozen plasma
• Prothrombin complex

This method of treatment is used very rarely to treat hemostasis disorder and is used only under some specific conditions. For instance, fresh frozen plasma and prothrombin complex is majorly used to treat severe hemorrhages. Advanced hemostats and sealants market consists of products which have came into existence in recent years and is considered as the best treatment option. Some of the products of this market are still under research pipeline. Advanced hemostats and sealants segment of the hemostasis market includes following categories:

• Flowable
• Thrombin
• Fibrin
• Synthetic sealants

In the hemostats and sealants market, several formulations of fibrinogen and thrombin have been developed, the most popular and commonly used product being the liquid fibrin sealant product in which the fibrinogen and thrombin are stored separately as lyophilized powder or frozen liquid. The other popular product which has captured large share of market is recothrom by the Medicines Company. Recrothrom is the human recombinant thrombin used as an aid for hemostasis. The market for this segment is increasing rapidly as these products act quickly and are safe in comparison to the topical agents. Topical agents sometimes cause infection leading to fatal consequences.

The hemostasis market is growing at a faster pace with Johnson & Johnson (JNJ) being the major market player. Johnson & Johnson offers distinguished products in hemostasis market under its wholly owned subsidiary Ethicon 360. Ethicon 360’s all products which are under hemostasis product portfolio are approved by the Food and Drug Administration (FDA). Recently, in October 2013, JNJ received clearance from FDA for Harmonic Ace +7, the first ultrasonic surgical devices indicated to seal vessels up to 7 mm. Extensive research and the new innovative products are the major reasons which are helping the market to grow. As recently, Arch Therapeutics, Inc. has developed a revolutionary product to stop bleeding faster than any other product available in market by the name AC5. AC5 is currently in preclinical testing and takes an average time of 15 seconds to stop bleeding in comparison to 80 seconds to 300 seconds taken by other treatments methods.

Some of the market players in Hemostasis market include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Siemens AG, Thermo Fisher Scientific, Inc., Trinity Biotech plc, Chrono-Log Corporation and The Medicines Company.

Global Report on Oxytocic Pharmaceuticals Market

Global Oxytocic Pharmaceuticals Market: Overview

Dubbed the “love hormone,” oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother. Oxytocic drugs can be used as uterotonic for induced labor and to reduce the chances of hemorrhage post C-section. Besides this, oxytocic drugs are also administered in conditions such as post-mature birth; uterine atony; pre-eclampsia, which means hypertension during pregnancy; stillbirth; postpartum hemorrhage; and as an adjunct therapy for treatment of autism and in cases of incomplete abortion.

Apart from being administered to humans, oxytocic drugs are also used as veterinary medications. Oxytocin demonstrates its effect after delivery, during childbirth, and toward the end stage of pregnancy.

According to the World Health Organization, every year more than 15 million babies are born prematurely, and this number of preterm births is expected to increase in the coming years. As per the findings of the National Center for Health Statistics, the U.S. alone exhibited a 23.3% labor induction rate in 2012. Considering these statistics, the demand for oxytocic drugs is expected increase significantly in the near future.

The report provides a comprehensive overview of the global oxytocic pharmaceuticals market. It presents insights into the factors influencing the market’s trajectory. The impact of the prevailing demand and supply trends on the market operations is also examined in the report in detail.

Global Oxytocic Pharmaceuticals Market: Key Opportunities and Threats

The increasing incidence of preterm births and the rising rates of labor induction are the primary factors fuelling demand from the global oxytocic pharmaceuticals market. The rising cases of pregnancy-related complications emerging in developing nations also translate into the increased use of oxytocic drugs. Additionally, the market is also expected to gain from the expansion of the health care and pharmaceutical industries in developing countries. However, awareness regarding the side effects related to oxytocic drugs can hamper their use to an extent, thereby restraining the global oxytocic pharmaceuticals market.

Leading brands offer numerous oxytocic products. Pitocin, Octocin, Evatocin, Syntocinon, Pitogin, Duratocin, Cytotec, and Tiacinon are the most popular brands competing for a larger share of the global oxytocic market. However, the synthetic oxytocin derivatives segment is poised to hold the largest share in the market owing to its easy availability. Likewise, hospitals are expected to emerge as the major end-use sector in the market.

Global Oxytocic Pharmaceuticals Market: Region-wise Outlook

Regionally, North America has been exhibiting the highest demand for oxytocic pharmaceuticals due to the high prevalence of induced labor in the region. Europe is expected to emerge as the second-largest market for oxytocic pharmaceuticals due to the rise in oxytocin administration in response to the increasing number of elective caesareans. The market is also anticipated to gain from the increasing case of C-sections in countries in Asia Pacific, such as India and China.

Get a Free Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11342

Global Oxytocic Pharmaceuticals Market: Vendor Landscape

To study the prevailing competitive landscape of the market, the report profiles companies such as APP Pharmaceuticals, LLC, LBS Labs, Baxter Healthcare Corporation, JHP Pharmaceuticals, LLC, and Pfizer Inc. The report studies these companies based on their business strategies, financial overview, and product portfolio. The strengths and weaknesses of these enterprises are analyzed. The report also presents in-depth overview of the threats and opportunities that these companies are expected to face during the forecast period.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Small Animal Imaging Market Dynamics and Opportunities Report by Transparency Market Research

Transparency Market Research (TMR) has recently published a report on the global small animal imaging market, according to which, the market is projected to rise at a healthy CAGR of 8.60% during the period from 2014 to 2020.The research report, titled “Small Animal Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” anticipates this market to increase from an overall value of US$1.5 bn in 2013 to an estimated value of US$2.7 bn by the end of the forecast period.

Small animal imaging technology has carved a niche for itself as one of the most helpful techniques used in preclinical research. The technology is mainly for obtaining preclinical images of small animals such as rats in order to carry out gene expression studies and various drug development research activities. Being a non-invasive technique, it provides an accurate and detailed longitudinal study on the subject.

The global market for small animal imaging market is witnessing a steady rise in its valuation thanks to the rapid proliferation of contract research organizations (CROs) in developing economies. This in turn is fueling the demand for contrast agents and preclinical imaging devices. The rising uptake of optical and multi-modal imaging devices in the global arena is also boosting this market significantly, notes the study.

In this research report, the global small animal imaging market has been evaluated on the basis of the device, reagent, application, and the region. Based on the device, the market has been classified into micro-MRI imaging, micro-CT imaging, micro-PET/SPECT imaging, micro-ultrasound imaging, optical imaging, multi-modal imaging, and micro-PAT. In 2013, the micro-MRI imaging devices segment held around 27 to 31% share and the optical imaging devices segment accounted for a share of approximately 12% to 17% in the global market.

The report has identified MRI contrast reagents, CT contrast reagents, nuclear imaging contrast reagents, ultrasound contrast reagents, and optical imaging contrast reagents as the major reagents available in this market. Cardiology, neurology and psychiatry, oncology, autoimmune diseases have been recognized as the prime application areas of small animal imaging market.

On the basis of region, the report has classified the global market for small animal imaging in Asia Pacific, North America, Europe, and the Rest of the World. North America dominated the overall market in 2013 and was closely followed by Europe. The increase in product launches, rise in preclinical research activities, and the escalating adoption rate of expensive devices have been driveing these regional markets since the last few years.

Request for Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2469

During the forecast period, the small animal imaging markets in Asia Pacific and the Rest of the World are likely to record a significant rise in their share due to the increasing number of CROs and the growth in the industry-based funding to conduct preclinical research, states the report.

The worldwide market for small animal imaging has consolidated in the recent past. Targeson Inc., SCANCO Medical AG, Siemens AG, Promega Corp., Perkin Elmer Inc., Miltenyi Biotec GmbH, FujiFilm VisualSonics Inc., LI-COR Biosciences Inc., TriFoil Imaging Inc., Bruker Corp., Aspect Imaging, and Agilent Technologies Inc. are the key companies operating in the global small animal imaging market, reports the research study.

The Emerging Role of Enteral Feeding Devices Market

Enteral feeding devices, also called as artificial nutrition support system are used to deliver nutrition or medication to the patients. These devices are considered as the first choice of treatment option for patients suffering with functional GI track. Increasing need of reconstructive surgeries coupled with technological advancements in these devices are expected to widen the market for enteral feeding devices. In addition, rising incidences of chronic diseases such as cancer, neurological and gastrointestinal disorders and increasing healthcare awareness are driving the demand for enteral feeding devices market globally. The global enteral feeding devices market is estimated to be USD 2,033.1 million in 2012 and is expected to reach USD 3,102.0 million by 2019, growing at a CAGR of 6.2% from 2013 to 2019.

Enteral feeding devices market is segmented mainly by product types and stages (age groups). Enteral feeding tubes, pumps, administration reservoir, giving sets and enteral syringes are major types of these devices based on product types. Enteral feeding devices market is further segmented by stages namely, pediatric and adult population. Enteral feeding devices market is witnessing a paradigm shift from the usage of parenteral devices to enteral feeding devices due to uptake of advanced technologies (such as low profile gastrostomy) and cost effective alternatives (e.g. enteral feeding tubes and giving sets). These devices have also gained widespread popularity because manufacturers are constantly coming up with new and innovative devices that are easy to use and have few complications. For example, introduction of balloon inflated gastrostomy tubes enable users to feed directly into the stomach so that feeding of nutrition and medication is possible without swallowing. This technique provides a safe and long term method for obtaining nutrition. Growing geriatric population coupled with rising preference of home enteral therapy has resulted in a steady rise in the demand of enteral feeding devices. In addition, introduction of International Organization for Standardization (ISO) and rising cases of preterm birth that demands feeding by enteral devices are the factors accentuating the growth of this market during the forecast period. However, complications related to enteral nutrition delivery such as diarrhea, gastrointestinal complications, and non-obstructive intestinal ischemia and stringent reimbursement policies restrains the market growth.

Request for Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=323

Europe contributed the largest share, i.e. over 35%, in 2012 of the global enteral feeding devices market. Rising geriatric population and increasing awareness about enteral nutrition are the major driving factors for the growth of enteral feeding devices market in Europe. North America contributed the second largest share i.e. over 30% of the total market in 2012. Preference for home based enteral therapy has led to reduction of frequent visits to clinics and hospitals, consequently increasing the uptake of enteral feeding devices in the North American region. The Asia-Pacific region is expected to witness the fastest growth due to expanding population coupled with rising number of preterm birth cases. High prevalence of gastrointestinal disorders and cancer are the contributing factors for the growth of enteral feeding devices market in this region.

In terms of key players, the global enteral feeding devices market is highly fragmented with the presence of large number of players that include Moog, Inc., Kimberly Clark, Amsino International, Inc., Applied Medical Technology, Inc., Boston Scientific, CONMED Corporation, Covidien plc and others.

Predicting response of Negative Pressure Wound Therapy For Wound care

Transparency Market Research (TMR) has recently published a study on the global negative pressure wound therapy (NPWT) market, according to which, the market is anticipated to rise at a healthy CAGR of 10.20% between 2014 and 2020.The research report, titled “Negative Pressure Wound Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” estimates this market to increase from a total value of US$1.5 bn in 2013 to US$2.9 bn by the end of the forecast period.

Negative pressure wound therapy is an advanced therapy that applies negative or sub-atmospheric pressure to a wound in a closed wound drainage system. The devices used in this therapy make use of a mechanical as well as an electrical suction pump to transfer negative pressure through connecting tubes to wound dressing kits to promote faster wound healing. These devices can be utilized for the treatment of pressure sores, traumatic wounds, surgical wounds, and chronic wounds such as venous stasis ulcers and diabetic foot ulcers.

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1718

According to the study, the NPWT market is likely to witness a robust rise in its valuation during the forecast period owing to the increasing incidence of acute and chronic wounds.The report has studied the global NPWT market on two fronts: Product and the region. Based on product, the market has been categorized into single-use NPWT devices and conventional NPWT devices. The conventional NPWT devices segment has been leading the overall market since the last decade. However, the single-use NPWT devices segment is projected to register a higher CAGR of approximately 17.0% over the forecast period.

The shift in preference of patients from conventional NPWT devices to single-use devices, on account of the convenience and the cost benefits offered by the latter, is likely to propel this market segment significantly in the coming years, notes the study.

Geographically, the report segments the worldwide NPWT market into Europe, North America, Asia Pacific, and the Rest of the World. North America emerged as the biggest regional market for NPWT in 2013. The increasing incidence of chronic diseases, rising awareness among patients regarding healthcare, and favorable reimbursement scenario have boosted this regional market.

In the same year, Europe acquired the second position in the global NPWT market on account of the augmented rate of transit accidents and increased incidence of chronic wounds.

Though both the regional markets are projected to record healthy growth during the forecast period, they are likely to lose ground to Asia Pacific market for NPWT. The NPWT market in Asia Pacific is expected to gain from the strengthening economy, supportive government policies, and the soaring demand for technically advanced wound care products in the coming years, states the report.

Devon Medical Inc., Talley Group Ltd., Smith & Nephew plc, Prospera Technologies LLC, Molnlycke Health Care AB, Kinetic Concepts Inc., Genadyne Biotechnologies Inc., ConvaTec Inc., and ArjoHuntleigh International AB are the major international players in the negative pressure wound therapy market, reports the study.

Cattle Biologics Manufacturing Market Segment Forecast up to 2020

Cattle biologics are defined as the vaccines, bacterins, diagnostics etc which helps to prevent, diagnose or treat the disease conditions in cattle and calves. These product works through some immunological pathway. The cattle biologics manufacturing market consist of four major segments on the basis of the products namely:

• Vaccines
• Pre-breeding vaccines for calves
• Antibodies
• Diagnostic kits

Among these categories, vaccines and pre-breeding vaccines for calves capture the major share of the market. Vaccines are provided to both cattle and calves, especially the new born calves to save them from various diseases such as clostridial diseases, anthrax, bovine virus diarrhea and vibriosis. On the basis of type of manufacturing the cattle biologics manufacturing market is divided into four main categories which include:

• Bacterins
• Bacterin Toxoid
• Non-bacterins
• Custom made Vaccines

Bacterins include vaccines which are made from killed bacteria, while the bacterin toxoids include vaccines which are made from live bacteria. In cattle vaccination, bacterin toxoid is preferred over other vaccination due to its long lasting effect. Texas Vet Lab, Inc. is one of the major market players of bacterins and bacterin toxoid and it is offering a wide range of products in its portfolio such as moraxella ovis, unique serovars of Salmonella and Histophilus Somni. Custom-made vaccines are also capturing a major part of the cattle biologics manufacturing market and have been complement to “off-the-shell” products in the U.S. market. Custom-made vaccines are the vaccines which are manufactured from the specific virus or bacteria which is major cause of disease in livestock operation. Newport Laboratories is one of the market players which is offering custom-made vaccines to the producers and veterinarians which gives them option to prepare a mixture of different products, modified according to producer that is not commercially available.

Download Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3608

Pre-breeding vaccination includes the vaccines, which are given to calves at the age between 12 months to 15 months. These vaccines are provided to calves to protect them against common reproductive diseases. On the basis of the vaccines which are provided to the calves, cattle biologics manufacturing market is divided into six major classes:

• Bovine Viral Diarrhea (BVD)
• Infectious Bovine Rhinotracheitis (IBR)
• Leptospirosis
• Bovine respiratory syncytial virus (BRSV)
• Clostridium
• Trichomoniasis

Among these the bovine viral diarrhea is most commonly used vaccine followed by leptospirosis and trichomoniasis. All these pre-breeding vaccinations protect calves from delayed breeding, smaller calves, potential abortions and persistently infected calves.

North America and Europe currently lead the cattle biologics manufacturing market majorly due to strong economic conditions and large number of cattle population. The major market of Europe is driven by Switzerland, which is known for cows and cattle. In 2010, there were 1,591, 233 cattle in Switzerland. Additionally, the government of U.S. and Europe has also setup some regulatory firms which are also helping the market to grow. As in Canada, the Canadian Food Inspection Agency (CFIA) regulates veterinary biologics and animal health products such as antibody products, vaccines, diagnostic kits that are used for the prevention, treatment and diagnosis of infectious diseases in animals. Other major market players in cattle biologics market include Addison Cattle Corporation, Agrilabs, Biocor Animal Health, Inc., Boehringer Ingelheim, Colorado Serum Company, Durvet, Inc., Fort Dodge Animal Health, Merial, Novartis AG and Pfizer, Inc.

Global Non-Invasive Prenatal Testing Market: Rising Average Maternal Age Worldwide to Fuel Market at 17.50% CAGR

Over the decade, the global non-invasive prenatal testing (NIPT) has shown a healthy growth. The rise in the global average of maternal age, coupled with the increasing incidence of Down syndrome in newborns, has boosted the market to a significant level. Additionally, the augmenting demand for timely and non-invasive fetal diagnosis is anticipated to propel the market in the coming years.

The global NIPT market is analyzed on the basis of the tests and the regional distribution of this market. Based on tests, the market is broadly classified into BambniTest, informaSeq, Harmony, MaterniT21 PLUS, Panorama, NIFTY, PrenaTest, VisibiliT, and verifi. Regionally, the worldwide market for NIPT is distributed among North America, Asia Pacific, Europe, and the Rest of the World.

The report present a comprehensive study of the global NIPT market with an analytical approach. Market drivers, restraints, opportunities, current and upcoming trends, and various segmentations of this market has been discussed at length in this study, making it a valuable source of guidance for market participants.

Overview of the Global NIPT Market

The global NIPT market stood at US$0.5 bn in 2013. Expanding at a CAGR of 17.50% over the period from 2014 to 2022, the market is projected to reach US$2.38 bn by the end of the forecast period.

According to the report, the first non-invasive prenatal test launched in the market was MaterniT21 PLUS. The test was introduced in 2011 and was intended to diagnose trisomy 21. In 2013, the market for MaterniT21 PLUS accounted for 36.1% of the total revenue generated in the NIPT market across the globe. However, this market segment is likely to lose ground on account of rising commercialization of panorama, Verifi, Bambni, and NIFTY during the forecast period.

The NIPT market in North America emerged as the largest regional market of the global NIPT market in 2013 with a 58.8% share in terms of revenue and a 51% share in terms of volume. The presence of major market participants in the U.S. and a high level of awareness pertaining to NIPT in North America has boosted the regional market extensively.

The Asia Pacific NIPT market is showing immense potential for growth. Australia, Japan, India, and China are the key markets for NIPT in this region. A large population base of women choosing late pregnancy is expected to drive the Asia Pacific market for NIPT market over the forecast period.

The presence of untapped opportunities in developing economies across the globe provides a huge potential market for participants. However, the strict regulatory guidelines regarding non-invasive prenatal testing and the availability of alternative screening and testing procedures are likely inhibit the growth of the market to an extent.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374

Companies mentioned in the research report

Laboratory Corporation of America Holdings, Berry Genomics Co. Ltd., Illumina Inc., LifeCodexx AG, Sequenom Inc., BGI Diagnostics, Ariosa Diagnostics Inc., and Natera Inc. are the major companies functioning in the global NIPT market. Strategic partnership and alliance with hospitals, medical research centers, and clinical laboratories are the key trends among the market participants for the expansion of their business.

Latin America Home Healthcare Market Holds Opportunities in CPAP Devices and Ventilators, to Reach US$17.5 bn by 2020

The Latin America home healthcare market is progressing at a CAGR of 8.70% within a forecast period of 2014 to 2020. This market is expected to reach US$17.5 bn by the end of 2020 from US$9.8 bn in 2013, as stated in the latest research report released by Transparency Market Research. The report is titled “Latin America Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

The home healthcare industry is dedicated to helping patients that suffer from illnesses that are chronic or recurring in nature. This allows patients to be away from the hospital and lead normal lives, while simultaneously allowing medical professionals to monitor the patient and provide prompt care whenever necessary. The two greatest advantages that home healthcare can offer are self-sufficiency for a patient in terms of physical wellbeing and a cost-effective strategy as it does not involve extra hospital visits and stays. This also helps healthcare organizations save internal space for other patients.

According to the report, the Latin America home healthcare market is currently being driven by a growing number of patients that are suffering from chronic illnesses. This driver is partly based on the growing geriatric population in Latin America and partly on the changing lifestyles that are making it increasingly conducive for people to suffer from chronic problems. The Latin America home healthcare market is therefore a primary benefactor of the increasing number of patients suffering from high blood pressure problems, diabetes, and COPD.

A key trend observed by the report’s analysts is the steady shift from conventional personal care to precision-based personal care models. These modern home healthcare services are highly suited for patients suffering from respiratory and cardiovascular diseases. These patients, along with the ones suffering from other major chronic illnesses, require constant monitoring for immediate medical intervention, a factor which has greatly boosted the Latin America home healthcare market.

For the sake of simplicity, the report divides the Latin America home healthcare market according to services and devices. The overall market for home healthcare-based devices has experienced a high growth rate in the recent past, owing to the rising adoption of modern medical devices across Latin America. It is also expected to show the fastest CAGR in the report’s forecast period. The Latin America healthcare industry is fast understanding the need and benefits of using advanced technologies, such as portable medical devices and automated devices.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3020

The market for CPAP devices and ventilators is expected to provide the widest range of opportunities. This market is expanding at a CAGR of 11.4% in the given forecast period.

In the case of services, the Latin America home healthcare market was dominated by unskilled home healthcare services in 2013 with a share of over 45%. In the current forecast period, this market is being spearheaded by the telehealth and telemedicine services, its fastest-growing services segment.

Brazil held nearly 35% of the Latin America home healthcare market in 2013, which was the largest market share, while 25% of the market was held by Mexico.

The key players in the Latin America home healthcare market include Praxair Technologies, Inc., Philips Healthcare, Medtronic, Inc., Hoffmanan-La Roche Ltd., Praxair Technologies, Inc., Teleflex Corp., Bayer Healthcare, ResMed, Inc., GE Healthcare, Cardinal Health, Gentiva Health Services, Inc., and Johnson & Johnson.